E823-0635 Screening compound: 1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl}propan-1-one

E823-0635 Screening compound: 1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl}propan-1-one
E823-0635 Screening compound: 1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl}propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound E823-0635
1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl}propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E823-0635

Molecular Formula

C27H38N6O4 (C27 H38 N6 O4)

Compound Name

1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-1,2,4-oxadiazol-5-yl}propan-1-one

IUPAC name

1-(morpholin-4-yl)-3-{3-[(4-{4-[(piperidin-1-yl)methyl]benzoyl}piperazin-1-yl)methyl]-124-oxadiazol-5-yl}propan-1-one

SMILES

O=C(CCc1nc(CN(CC2)CCN2C(c2ccc(CN3CCCCC3)cc2)=O)no1)N1CCOCC1

InChI

InChI=1S/C27H38N6O4/c34-26(32-16-18-36-19-17-32)9-8-25-28-24(29-37-25)21-31-12-14-33(15-13-31)27(35)23-6-4-22(5-7-23)20-30-10-2-1-3-11-30/h4-7H,1-3,8-21H2

InChI Key

AVRGIWHAVZHJGY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14920661

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

510.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.562

Distribution Coefficient, logD

-0.889

Water Solubility, LogSw

-1.56

Polar Surface Area

80.794

Acid Dissociation Constant (pKa)

23.79

Base Dissociation Constant (pKb)

8.84

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.00

E823-0635 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E823-0635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E823-0635?
Check Price and Availability of E823-0635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E823-0635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E823-0635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E823-0635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E823-0635 available by request